Company intelligence / Profile preview

Protea Biosciences

Morgantown, West Virginia, United Statesproteabio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Protea Biosciences develops and commercializes innovative bioanalytical technologies focused on improving the identification, characterization, and analysis of proteins and other biomolecules from biological samples. Their products include advanced sample preparation systems such as the Gel Protein Recovery System for proteomics workflows. The company also offers contract research services in mass spectrometry imaging and liquid chromatography-mass spectrometry to support pharmaceutical R&D.

Modalities: ProteinRecombinant proteinDeviceSmall molecule
Industry: Non-Drug Biotech

Partnerships

ModaPharma (sponsored)

Beyond the preview

Go deeper on Protea Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protea Biosciences.

Explore the full profile